Tools & Calculators
Sector: Pharmaceuticals & Biotechnology
|Mid Cap
Rubicon Research Ltd.
₹783.65
₹773.00
₹797.00
₹570.75
₹822.00
Markets Today
Historical Performance
Indicator | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| Total Revenue | 301.71 | 336.47 | 278.03 | 300.81 | 244.87 |
| Operating Expense | 239.46 | 257.37 | 214.88 | 239.50 | 180.97 |
| Operating Profit | 62.25 | 79.10 | 63.14 | 61.30 | 63.90 |
| Depreciation | 9.51 | 9.78 | 8.30 | 8.57 | 7.93 |
| Interest | 7.51 | 9.21 | 8.85 | 10.78 | 7.25 |
| Tax | 12.35 | 15.82 | 12.28 | 13.66 | 12.82 |
| Net Profit | 37.18 | 45.81 | 35.15 | 40.27 | 38.23 |
₹783.65
↗ Bullish Moving Average
10
↘ Bearish Moving Average
3
| Held By | Dec 2025 |
|---|---|
| Promoter | 60 |
| FII | 8 |
| DII | 9.4 |
| Public | 22.6 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 1.53 L | 2.42 L | 63.49% |
| Week | 1.47 L | 2.62 L | 56.07% |
| 1 Month | 1.05 L | 1.94 L | 54.26% |
| 6 Month | 2.57 L | 5.65 L | 45.48% |
Benjamin Graham Value Screen
Companies with 10% increase in share price over three months, with rising net profit growth
Consistent high performing stocks over Five Years
Relative Outperformance versus Industry over 1 Month
Rising Net Cash Flow and Cash from Operating activity
Relative Outperformance versus Industry over 1 Year
Annual Profit Growth higher than Sector Profit Growth
Good quarterly growth in the recent results
Relative Outperformance versus Industry over 1 Month
Companies with rising net profit margins - quarterly as well as TTM basis
Effectively using its capital to generate profit - RoCE improving in last 2 years
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Growth in Net Profit with increasing Profit Margin (QoQ)
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Increasing profits every quarter for the past 3 quarters
Increasing Revenue every quarter for the past 2 quarters
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Annual Net Profits improving for last 2 years
Companies with Zero Promoter Pledge
Top Gainers
Stocks near 52 Week High with Significant Volumes
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| No Record Found | ||||
Financials | |||||
|---|---|---|---|---|---|
| Price (₹) | ₹1,546.20 | ₹614.65 | ₹1,463.50 | ₹4,512.30 | ₹495.05 |
| % Change | -0.63% | 3.73% | -0.67% | 4.98% | 6.21% |
| Revenue TTM (₹ Cr) | - | - | ₹1,419.33 | ₹878.40 | ₹4,256.70 |
| Net Profit TTM (₹ Cr) | - | - | ₹20.10 | ₹240.10 | ₹318.19 |
| PE TTM | - | - | 840.10 | 41.20 | 23.10 |
| 1 Year Return | 46.52 | -0.08 | -15.92 | -10.95 | -1.5 |
| ROCE | 30.24 | 34.78 | 3.26 | - | 11.27 |
Blue Jet Healthcare Ltd
₹ 347.70
+6.25%
Concord Biotech Ltd.
₹ 1019.70
+0.13%
Aarti Pharmalabs Ltd.
₹ 627.85
+6.06%
Piramal Pharma Ltd.
₹ 141.64
+3.74%
Acutaas Chemicals Ltd.
₹ 2304.10
-9.95%
Alivus Life Sciences Ltd.
₹ 991.55
+1.94%
Cohance Lifesciences Ltd.
₹ 308.80
+2.44%
Eris Lifesciences Ltd.
₹ 1301.00
+0.29%
Syngene International Ltd.
₹ 394.70
+1.23%
Alembic Pharmaceuticals Ltd.
₹ 675.60
+1.86%
Strides Pharma Science Ltd.
₹ 961.85
+2.57%
Granules India Ltd.
₹ 630.00
+1.55%
Wockhardt Ltd.
₹ 1263.40
+7.46%
FDC Ltd.
₹ 327.15
+1.88%
Shilpa Medicare Ltd.
₹ 371.80
+6.56%
Jubilant Pharmova Ltd.
₹ 816.10
-0.04%
Natco Pharma Ltd.
₹ 1000.60
+2.71%
Caplin Point Laboratories Ltd.
₹ 1568.70
+4.25%
Neuland Laboratories Ltd.
₹ 12570.00
+4.51%
Marksans Pharma Ltd.
₹ 166.49
+6.12%
Sanofi India Ltd.
₹ 3247.50
+1.18%
Procter & Gamble Health Ltd.
₹ 4805.10
+0.13%
Jeena Sikho Lifecare Ltd.
₹ 579.15
+7.31%
By signing up I certify terms, conditions & privacy policy